EHC vs PACS stock comparison
Encompass Health vs. PACS Group · data as of November 13, 2026
Encompass Health (EHC) has a market value of about $13.8B, PACS Group (PACS) about $7.7B. Over their latest twelve months Encompass Health had revenue of $6.3B and PACS Group $5.7B.
On our five checks Encompass Health scores higher: 3.6 out of 5 (good) against 2.4 (weak).
By area, the stronger company is PACS Group on future growth; Encompass Health on track record; Encompass Health on financial health; Encompass Health on shareholder returns.
Encompass Health is cheaper on earnings (P/E 22.0 vs. 27.5).
Encompass Health leads on 12 of the compared lines and PACS Group on 8.
Side by side
| EHC | PACS | |
|---|---|---|
| Size and price | ||
| Market cap | $13.8B | $7.7B |
| Share price | $140.99 | $48.32 |
| Score | ||
| Overall score (of 5) | 3.6 | 2.4 |
| Value | 2 | 2 |
| Future growth | 4 | 5 |
| Track record | 5 | 2 |
| Financial health | 3 | 2 |
| Shareholder returns | 4 | 1 |
| Valuation | ||
| P/E (TTM) | 22.0 | 27.5 |
| Forward P/E | 20.9 | 17.5 |
| Price / free cash flow | 30.3 | 17.1 |
| Price / sales | 2.2 | 1.3 |
| EV / EBITDA | 10.7 | 22.0 |
| PEG | 1.55 | — |
| DCF value vs. price | −46% | +16% |
| Business | ||
| Revenue | $6.3B | $5.7B |
| Net income | $644M | $278M |
| Free cash flow | $457M | $448M |
| Net margin | 10.2% | 4.9% |
| Gross margin (5-yr avg.) | — | — |
| ROIC (5-yr avg.) | 12.2% | 63.9% |
| Growth | ||
| Revenue growth (1 yr) | 10.5% | 29.3% |
| Revenue growth (5 yrs, per year) | 10.7% | — |
| EPS growth (5 yrs, per year) | 14.2% | — |
| Balance sheet and payouts | ||
| Net cash (cash minus debt) | -$2.7B | -$3.3B |
| Dividend yield | 0.60% | None |
| Shareholder yield | 1.7% | 0.0% |
| Analysts | ||
| Upside to average target | +11% | +29% |
| Consensus rating | Strong buy | Strong buy |
Highlighted = the better figure on that line. Revenue, net income and free cash flow: EHC TTM to September 30, 2026, PACS TTM to September 30, 2026. Not investment advice.
Frequently asked questions
Which is the better stock, Encompass Health or PACS Group?
We do not give buy or sell advice. On our five checks (value, growth, track record, financial health and shareholder returns) Encompass Health scores 3.6 out of 5 and PACS Group 2.4; the table shows where each one is stronger.
Is Encompass Health cheaper than PACS Group?
On trailing earnings, Encompass Health trades at a P/E of 22.0 and PACS Group at 27.5, so Encompass Health is cheaper by this measure. A lower P/E can also reflect slower expected growth.
Which pays a higher dividend?
Encompass Health yields 0.60% and PACS Group nothing (no dividend).
Full Encompass Health analysis → Full PACS Group analysis →
More comparisons
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.